New York, USA, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who ...

Recently, actress Lili Reinhart opened up about her health battle, revealing she was diagnosed with interstitial cystitis ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it.

Researchers reveal how targeting HIF2 could transform the treatment of idiopathic pulmonary fibrosis (IPF), offering hope for ...

Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses.

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Interstitial Lung Disease ...

Discover a recent study that revealed that interstitial cystitis patients were older, predominantly female, and exhibited ...

Mayo Clinic researchers find that stem cells with the highest Myc expression become dominant in driving lung remodeling .

It will provide care for a group of disorders that may progress to pulmonary fibrosis. Asian Hospital and Medical Centre (AHMC), supported by Boehringer Ingelheim (Philippines) Inc., has launched the ...